A phase II combination study of bortezomib with pegylated-liposomal doxorubicin in patients with ovarian cancer failing platinum containing regimens

被引：0
|
作者：
Scambia, G.
Parma, G.
Del Conte, G.
Hess, D.
Gadducci, A.
Katsaros, D.
Sessa, C.
Trudel, G. C.
Coceani, N.
Colombo, N.
机构：
[1] Univ Cattolica Sacro Cuore, Campobasso, Italy
[2] Ist Europeo Oncol, Milan, Italy
[3] Ist Nazl Tumori, I-20133 Milan, Italy
[4] Kantonsspital St Gallen, St Gallen, Switzerland
[5] Univ Pisa, Pisa, Italy
[6] Univ Turin, Turin, Italy
[7] Osped San Giovanni Bellinzona, Bellinzona, Switzerland
[8] Johnson & Johnson, Beerse, Belgium
[9] Sendo, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.5581
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5581
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Trabectedin in combination with pegylated liposomal doxorubicin for patients with ovarian cancer
    Tavella, K.
    Villanucci, A.
    Vannini, L.
    Montelatici, S.
    Lavacchi, D.
    Boni, L.
    Tomcikova, D.
    Amunni, G.
    Mazzei, T.
    ANNALS OF ONCOLOGY, 2016, 27
  • [12] A phase I/II study of maplirpacept in combination with pegylated liposomal doxorubicin (PLD) in patients with platinum-resistant ovarian cancer (OC): Phase 1 results
    Street, Daron G.
    Kuttschreuter, Luke
    Starks, David
    Mahdi, Haider
    Linn, Carlos
    Pavlov, Dmitri
    Peguero, Julio Antonio
    Chawla, Sant P.
    Bruns, Ingmar
    Waggoner, Steven E.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [13] Phase II study of combination therapy with pegylated liposomal doxorubicin (PLD) and carboplatin in patients (pts) with relapsed, platinum sensitive and platinum semi-sensitive ovarian cancer
    Rapoport, B. L.
    Vorobiof, D. A.
    Slabber, C.
    Cohen, G.
    Alberts, A. S.
    Hlophe, H. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [14] Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer
    Rivera, E
    Valero, V
    Arun, B
    Royce, M
    Adinin, R
    Hoelzer, K
    Walters, R
    Wade, JL
    Pusztai, L
    Hortobagyi, GN
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) : 3249 - 3254
  • [15] Phase II Study of Pegylated Liposomal Doxorubicin and Carboplatin in Patients With Platinum-Sensitive and Partially Platinum-Sensitive Metastatic Ovarian Cancer
    Rapoport, B. L.
    Vorobiof, D. A.
    Slabber, C.
    Alberts, A. S.
    Hlophe, H. S.
    Mohammed, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (06) : 1137 - 1141
  • [16] A phase Ib study of IN10018 in combination with pegylated liposomal doxorubicin (PLD) in patients with platinum-resistant ovarian cancer.
    Wu, Lingying
    Wang, Jing
    Wang, Li
    Lu, Weiguo
    Wang, Ke
    Lin, An
    Li, Ning
    Li, Li
    Su, Ning
    Xie, Shuang
    Jiang, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [17] Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
    John J Kavanagh
    Charles F Levenback
    Pedro T Ramirez
    Judith L Wolf
    Carla L Moore
    Marsha R Jones
    Lisa Meng
    Gail L Brown
    Robert C Bast
    Journal of Hematology & Oncology, 3
  • [18] Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
    Kavanagh, John J.
    Levenback, Charles F.
    Ramirez, Pedro T.
    Wolf, Judith L.
    Moore, Carla L.
    Jones, Marsha R.
    Meng, Lisa
    Brown, Gail L.
    Bast, Robert C., Jr.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2010, 3
  • [19] A multicenter phase II study of pegylated liposomal doxorubicin and oxaliplatin in recurrent ovarian cancer
    Recchia, Francesco
    Saggio, Gaetano
    Amiconi, Giovanna
    Di Blasio, Anna
    Cesta, Alisia
    Candeloro, Giampiero
    Carta, Gaspare
    Necozione, Stefano
    Mantovani, Giovanni
    Rea, Silvio
    GYNECOLOGIC ONCOLOGY, 2007, 106 (01) : 164 - 169
  • [20] Phase II study of pegylated liposomal doxorubicin and oxaliplatin in relapsed advanced ovarian cancer
    Nicoletto, MO
    Falci, C
    Pianalto, D
    Artioli, G
    Azzoni, P
    De Masi, G
    Ferrazzi, E
    Perin, A
    Donach, M
    Zoli, W
    GYNECOLOGIC ONCOLOGY, 2006, 100 (02) : 318 - 323
12345